116 filings
Page 6 of 6
8-K
osvqru
1 Aug 17
CRISPR Therapeutics Appoints Dr. Tony W. Ho to Head Research & Development
12:00am
8-K
08ti6zc1y94ztxid9p
27 Jul 17
Departure of Directors or Certain Officers
12:00am
8-K
mg8u0ig 2n
25 Jul 17
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
pfwg44fytd9ds0mx
25 Jul 17
Other Events
12:00am
8-K
v9ant7
19 Jun 17
CRISPR Therapeutics Announces Patent
12:00am
8-K
cxj56p5o496 3u
8 Jun 17
CRISPR Therapeutics Appoints James R. Kasinger as General Counsel
12:00am
8-K
ug8di 6qxu
2 Jun 17
Departure of Directors or Certain Officers
12:00am
8-K
7pc yhiwf
11 May 17
Results of Operations and Financial Condition
12:00am
8-K
022q1i jk5cxv
4 May 17
Departure of Directors or Certain Officers
12:00am
8-K
9h9skro33orrut8 yld
27 Apr 17
Intellia Therapeutics and CRISPR Therapeutics Announce
12:00am
8-K
ztk2f4jqw7zt5iq
13 Apr 17
CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics Announce Appeal of CRISPR/Cas9 U.S. Patent Board Decision
12:00am
8-K
3hnbpn 1y
31 Mar 17
CRISPR Therapeutics Announces European Patent
12:00am
8-K
ve8q4oqdgdijk7z1fay7
20 Mar 17
Departure of Directors or Certain Officers
12:00am
8-K
2m8fv14 qfs
15 Feb 17
Other Events
12:00am
8-K
zc1o0poprvql pk1e0sz
16 Dec 16
Entry into a Material Definitive Agreement
12:00am
8-K
3ulul85swbyn8b4
8 Nov 16
Amendments to Articles of Incorporation or Bylaws
12:00am